# Fulcrum Therapeutics, Inc.: Form 8-K, filed Jun 4, 2026

- Company: [Fulcrum Therapeutics, Inc.](/companies/fulc.md) (CIK 1680581)
- Form: 8-K
- Filed: 2026-06-04
- Accepted by EDGAR: Jun 4, 2026, 16:05 ET
- Period: 2026-05-31
- Accession: 0001193125-26-257376
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1680581/000119312526257376/fulc-20260531.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1680581/000119312526257376/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1680581/000119312526257376/fulc-20260531.htm

Filed Jun 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-257376. Last ingested by Listed: Nov 14, 2026, 23:09 ET. No prices; not investment advice.
